Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO01235
Host Cell : HEK293 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO01235 |
| Description | This cell line is engineered to stably overexpress wild type human solute carrier family 6 member 3 (SLC6A3). |
| Product Type | SLC Transporter Stable Cell Lines |
| Target Gene | SLC6A3 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HEK293 |
| Host Cell Species | Homo sapiens (Human) |
| Size | One vial of frozen cells, typically >1x10^6cells/vial |
| Quality Control |
1) Real-Time qPCR 2) Mycoplasma detection |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Media Type | Cells were cultured in DMEM supplemented with 10% fetal bovine serum. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6. |
| Freeze Medium | Complete medium supplemented with 10% (v/v) DMSO |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Target Gene | SLC6A3 |
| Background | This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.[provided by RefSeq, Nov 2009] |
The human dopamine transporter (DAT), encoded by the SLC6A3 gene (also known as DAT1), is a membrane-bound protein responsible for the reuptake of dopamine from the synaptic cleft back into presynaptic neurons. This sodium- and chloride-dependent transporter belongs to the solute carrier family 6 and plays a central role in the regulation of dopaminergic signaling, which impacts motor control, reward, cognition, and hormone release. The Human SLC6A3 Stable Cell Line - HEK293 is generated by transfecting HEK293 cells with a human SLC6A3 expression construct, followed by stable selection to ensure consistent and long-term expression of the functional dopamine transporter on the cell surface. This cell line provides a reliable and reproducible in vitro system for studying DAT biology, transporter kinetics, and ligand interactions without the need for repeated transfections or primary neuron culture.
This stable cell line is widely used in drug discovery and neuroscience research, particularly for screening compounds that modulate dopamine transporter activity. It is well suited for dopamine uptake assays, radioligand binding studies, and electrophysiological recordings to evaluate the potency and selectivity of potential inhibitors or substrates. Researchers also employ this line to investigate the molecular mechanisms underlying DAT-related disorders, including attention-deficit hyperactivity disorder, Parkinson’s disease, substance use disorders, and depression. Additionally, the line can support toxicological studies examining how environmental toxins or drugs of abuse, such as cocaine and amphetamines, affect transporter function and trafficking. The HEK293 background offers high transfection efficiency, robust protein expression, and ease of culture, making it a practical tool for both academic and pharmaceutical laboratories focused on dopaminergic pathway research.
The ability of dopamine (DAT), norepinephrine (NET), and serotonin (SERT) transporters to concentrate substrates is generally considered to be driven by the transmembrane sodium ion (Na+) gradient, though it may also utilize other energy sources, such as membrane potential and/or the transmembrane potassium ion (K+) gradient. To investigate this, researchers used voltage-controlled recordings to monitor the uptake of endogenous substrates or the fluorescent substrate APP+ (4-(4-dimethylaminophenyl)-1-methylpyridinium) in cells expressing DAT, NET, or SERT. The results indicate that DAT and NET differ from SERT in their handling of intracellular potassium ions (K+). For DAT and NET, substrate uptake is voltage-dependent because the transient nature of intracellular K+ binding hinders K+ antiport; in contrast, SERT is capable of K+ antiport, thereby enabling voltage-independent transport. Consequently, there is a trade-off between maintaining a constant uptake rate and utilizing membrane potential to concentrate substrates; the researchers suggest that this difference stems from subtle variations in the co-transported ion binding kinetics among these closely related transporters.
Here, researchers combined the advantages of transporter-targeted radiotracer assays and electrophysiological techniques to establish an experimental system for measuring APP+ (Figure 1A) uptake in a single DAT-, NET-, or SERT-expressing HEK293 cell under voltage-controlled conditions (Figure 1B, left). The schematic in Figure 1C illustrates the transport cycle of Na+/Cl−-coupled secondary active transporters. Figure 1D displays representative dual-channel recording traces obtained from control (untransfected) HEK293 cells or from DAT-, NET-, or SERT-expressing HEK293 cells that were voltage-clamped at −60 mV and exposed to 100 µM APP+. In control HEK293 cells, the perfusion (wash-in) and washout of APP+ caused a rapid, transient rise and fall in the fluorescence signal, respectively, without accompanying changes in current. In DAT-expressing cells, APP+ induced an inward current comprising both peak and steady-state components, indicating that APP+ is a substrate for DAT. The transport of APP+ into DAT-expressing cells also resulted in a slow rise in the fluorescence signal; this increase was linear over time and ceased upon APP+ removal. The fluorescence signal subsequently returned to a new baseline level, indicating intracellular trapping of APP+. In contrast, APP+ induced only an inward peak current-without a steady-state current-in cells expressing NET or SERT. Although the absence of APP+-induced steady-state currents in SERT- and NET-expressing cells might suggest that APP+ is not transported by these carriers, the intracellular accumulation of APP+ in these cells increased linearly over time. This indicates that APP+ transport does occur, albeit with lower efficiency. The rapid rise and fall of the fluorescence signal associated with APP+ wash-in and washout, observed in control cells, were also evident in DAT-, NET-, or SERT-expressing cells.
Figure 1. Simultaneous measurements of fluorescence and currents. (Bhat S, et al., 2021)
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
This SLC6A3 (DAT) stable cell line in HEK293 is a high-quality tool for studying dopamine reuptake and transporter pharmacology. The transporter expression is stable and functional, with robust dopamine uptake activity that can be blocked by known inhibitors. It has been a reliable workhorse for our neuropharmacology assays.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.